Dätwyler Holding (DAE) Stock Overview
Engages in the production and sale of elastomer components for healthcare, automotive, industries, and food and beverage industries in Switzerland, rest of Europe, North and South America, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
DAE Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CE
Ceazar
Community ContributorCA$5.25FV • 1.3% overvalued intrinsic discount
30989.3%Revenue growth p.a.
966
4
0
18
Dätwyler Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 157.00 |
| 52 Week High | CHF 171.60 |
| 52 Week Low | CHF 112.20 |
| Beta | 1.09 |
| 1 Month Change | 11.35% |
| 3 Month Change | -0.51% |
| 1 Year Change | 32.15% |
| 3 Year Change | -33.19% |
| 5 Year Change | -46.60% |
| Change since IPO | 1,306.17% |
Recent News & Updates
DAE: Steady Outlook Will Reflect Balanced Assumptions And Stable Market Expectations
Analysts are maintaining their CHF 143.00 price target for Dätwyler Holding, as small adjustments to discount rate, revenue growth and profit margin assumptions are viewed as offsetting, alongside a slightly lower estimate for the future P/E multiple. Valuation Changes Fair Value: CHF 143.00 fair value estimate is unchanged, and the same target level is maintained.
DAE: Drug Delivery Collaboration Will Support Bullish Outlook On Future Earnings
Analysts have nudged their fair value estimate for Dätwyler Holding from CHF 178.00 to about CHF 179.67. This reflects slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a modestly higher price target in CHF terms.DAE: Drug Delivery Partnership Will Support Steady Outlook At Current Valuation
Analysts now hold Dätwyler Holding's fair value steady at about CHF 143, with only slight model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions driving a very marginal change in their overall price target stance. What's in the News Dätwyler Holding announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large-volume subcutaneous drug delivery through convenient on-body administration of larger doses for patients and market needs (Key Developments).DAE: Collaboration In Drug Delivery Will Support Steady Long Term Outlook
Analysts have raised their CHF price target on Dätwyler Holding from CHF129 to CHF143, citing updated assumptions for fair value, a slightly higher discount rate, adjusted revenue growth expectations, a modest change in profit margin outlook, and a revised future P/E multiple. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group focused on large volume subcutaneous drug delivery and on-body administration solutions for patients using biologics and other sensitive therapies (Key Developments).Recent updates
DAE: Steady Outlook Will Reflect Balanced Assumptions And Stable Market Expectations
Analysts are maintaining their CHF 143.00 price target for Dätwyler Holding, as small adjustments to discount rate, revenue growth and profit margin assumptions are viewed as offsetting, alongside a slightly lower estimate for the future P/E multiple. Valuation Changes Fair Value: CHF 143.00 fair value estimate is unchanged, and the same target level is maintained.DAE: Drug Delivery Collaboration Will Support Bullish Outlook On Future Earnings
Analysts have nudged their fair value estimate for Dätwyler Holding from CHF 178.00 to about CHF 179.67. This reflects slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a modestly higher price target in CHF terms.DAE: Drug Delivery Partnership Will Support Steady Outlook At Current Valuation
Analysts now hold Dätwyler Holding's fair value steady at about CHF 143, with only slight model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions driving a very marginal change in their overall price target stance. What's in the News Dätwyler Holding announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large-volume subcutaneous drug delivery through convenient on-body administration of larger doses for patients and market needs (Key Developments).DAE: Collaboration In Drug Delivery Will Support Steady Long Term Outlook
Analysts have raised their CHF price target on Dätwyler Holding from CHF129 to CHF143, citing updated assumptions for fair value, a slightly higher discount rate, adjusted revenue growth expectations, a modest change in profit margin outlook, and a revised future P/E multiple. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group focused on large volume subcutaneous drug delivery and on-body administration solutions for patients using biologics and other sensitive therapies (Key Developments).DAE: Outlook Will Balance Drug Delivery Collaboration With Moderated Profit Expectations
Analysts have raised their fair value estimate for Dätwyler Holding from CHF 158 to CHF 178, citing updated assumptions related to revenue growth, profit margins and a higher future P/E multiple. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large volume subcutaneous drug delivery, focusing on convenient on body administration that aims to meet evolving patient and market needs (Key Developments).Dätwyler Holding (VTX:DAE) Is Paying Out A Dividend Of CHF3.20
Feb 15
DAE: Large Volume Drug Delivery Collaboration Will Support Attractive Future Share Upside
Analysts have maintained their price target for Dätwyler Holding at CHF 185.00, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E that fine tune rather than overhaul their prior view. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group aimed at broadening large volume subcutaneous drug delivery through convenient on body administration of larger doses to address evolving patient and market needs (Key Developments).DAE: Large Volume Drug Delivery Partnership Will Support Stable Future Share Performance
Analysts have kept their price target for Dätwyler Holding steady at CHF 185, citing only slight adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E that did not materially alter their valuation view. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large volume subcutaneous drug delivery through on body self administration solutions for patients and pharmaceutical customers (Key Developments).DAE: Higher Margin Outlook Will Support Stronger Future Share Performance
Analysts now place their fair value estimate for Dätwyler Holding at CHF 185, up from CHF 174, citing updated assumptions for revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value Estimate was raised from CHF 174 to CHF 185, indicating a modest upward adjustment in the intrinsic assessment.Is Dätwyler Holding AG (VTX:DAE) Worth CHF166 Based On Its Intrinsic Value?
Jan 07DAE: Higher Future Earnings Multiple Will Drive Stronger Share Performance
Analysts have raised their price target on Dätwyler Holding from CHF 143 to CHF 174, citing slightly firmer long term revenue growth expectations, improved profit margin forecasts, and a higher anticipated future valuation multiple. Valuation Changes Fair Value: increased from CHF 143 to CHF 174, representing a material upward revision to the target level.Dätwyler Holding AG's (VTX:DAE) Popularity With Investors Is Under Threat From Overpricing
Dec 04DAE: Outlook Will Balance Faster Revenue Outlook With Modestly Higher Profit Margins
Analysts have raised their price target for Dätwyler Holding from CHF 144.25 to CHF 158.00, reflecting increased confidence in faster revenue growth, slightly higher profit margins, and a modestly richer future earnings multiple. Valuation Changes The Fair Value Estimate has risen moderately from CHF 144.25 to CHF 158.00, suggesting a higher intrinsic value assessment for Dätwyler Holding.DAE: Updated Fair Value Reflects Balanced Outlook Amid Rate Adjustments
Analysts have raised their fair value estimate for Dätwyler Holding from CHF 138 to CHF 144.25. They cite updated assumptions around revenue growth, profit margins, and discount rates as reasons for this change.At CHF148, Is It Time To Put Dätwyler Holding AG (VTX:DAE) On Your Watch List?
Oct 07Dätwyler Holding AG's (VTX:DAE) Intrinsic Value Is Potentially 33% Above Its Share Price
Sep 22High-value Healthcare And Electric Vehicles Will Transform Future Markets
The notable reduction in Dätwyler Holding's consensus analyst price target is primarily driven by a significant decrease in its future P/E multiple, with fair value now revised downward to CHF138.00. Valuation Changes Summary of Valuation Changes for Dätwyler Holding The Consensus Analyst Price Target has significantly fallen from CHF154.20 to CHF138.00.These 4 Measures Indicate That Dätwyler Holding (VTX:DAE) Is Using Debt Reasonably Well
Aug 11Dätwyler Holding AG's (VTX:DAE) Shares Climb 26% But Its Business Is Yet to Catch Up
Jul 26Should You Think About Buying Dätwyler Holding AG (VTX:DAE) Now?
Jul 08Dätwyler Holding AG's (VTX:DAE) Earnings Haven't Escaped The Attention Of Investors
May 13Is Now An Opportune Moment To Examine Dätwyler Holding AG (VTX:DAE)?
Apr 03Dätwyler Holding's (VTX:DAE) Dividend Will Be CHF3.20
Mar 19
ForwardNow Will Streamline Operations, Focusing On High-Margin Products And Sustainable Practices
The ForwardNow program's optimization and focus on high-margin products aim to boost profitability and net margins.Is Dätwyler Holding (VTX:DAE) Using Too Much Debt?
Mar 01Dätwyler Holding's (VTX:DAE) Soft Earnings Are Actually Better Than They Appear
Feb 14Dätwyler Holding AG (VTX:DAE) Shares Could Be 39% Below Their Intrinsic Value Estimate
Dec 13Dätwyler Holding AG (VTX:DAE) Not Lagging Market On Growth Or Pricing
Nov 06Dätwyler Holding AG (VTX:DAE) Just Released Its Interim Earnings: Here's What Analysts Think
Jul 27Estimating The Fair Value Of Dätwyler Holding AG (VTX:DAE)
Jul 17Is There Now An Opportunity In Dätwyler Holding AG (VTX:DAE)?
Jun 13Does Dätwyler Holding (VTX:DAE) Have A Healthy Balance Sheet?
Apr 17A Look At The Fair Value Of Dätwyler Holding AG (VTX:DAE)
Apr 01Dätwyler Holding's (VTX:DAE) Dividend Will Be CHF3.20
Mar 17Earnings Miss: Dätwyler Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts
Feb 10Is It Time To Consider Buying Dätwyler Holding AG (VTX:DAE)?
Feb 05Dätwyler Holding AG's (VTX:DAE) P/E Is On The Mark
Dec 22Is Dätwyler Holding (VTX:DAE) A Risky Investment?
Nov 03Is Now An Opportune Moment To Examine Dätwyler Holding AG (VTX:DAE)?
Oct 19A Look At The Fair Value Of Dätwyler Holding AG (VTX:DAE)
Aug 12Dätwyler Holding (VTX:DAE) Seems To Use Debt Quite Sensibly
Jul 25What Does Dätwyler Holding AG's (VTX:DAE) Share Price Indicate?
May 20Is Dätwyler Holding (VTX:DAE) A Risky Investment?
Apr 10When Should You Buy Dätwyler Holding AG (VTX:DAE)?
Feb 10Is Dätwyler Holding (VTX:DAE) Using Too Much Debt?
Dec 29At CHF181, Is It Time To Put Dätwyler Holding AG (VTX:DAE) On Your Watch List?
Oct 29Does Dätwyler Holding (VTX:DAE) Have A Healthy Balance Sheet?
Sep 20Shareholder Returns
| DAE | CH Machinery | CH Market | |
|---|---|---|---|
| 7D | 3.7% | -1.4% | -0.9% |
| 1Y | 32.2% | -3.9% | 8.3% |
Return vs Industry: DAE exceeded the Swiss Machinery industry which returned -5% over the past year.
Return vs Market: DAE exceeded the Swiss Market which returned 7.3% over the past year.
Price Volatility
| DAE volatility | |
|---|---|
| DAE Average Weekly Movement | 4.0% |
| Machinery Industry Average Movement | 5.1% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in CH Market | 8.3% |
| 10% least volatile stocks in CH Market | 2.2% |
Stable Share Price: DAE has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: DAE's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1915 | 7,823 | Volker Cwielong | www.datwyler.com |
Dätwyler Holding AG engages in the production and sale of elastomer components for healthcare, automotive, industries, and food and beverage industries in Switzerland, rest of Europe, North and South America, Asia, and internationally. It operates in two divisions, Healthcare and Industrial. The Healthcare division offers rubber components for prefilled syringes, pens, and injection systems; components and closures for injectable drugs in vials; and rubber components for blood collection systems, IV administration sets, disposable syringes, diagnostics and medical devices, etc. The Industrial division provides batteries and powertrains in electric vehicles, brake systems, interior and active assistance and safety systems in various cars, as well as fuel and engine management and exhaust gas aftertreatment in combustion engines; seals and components for electrical connectors; sealing solutions; and sealing components for upstream systems in the oil and gas, aerospace, heavy machinery, power tools and process, and water treatment industries.
Dätwyler Holding AG Fundamentals Summary
| DAE fundamental statistics | |
|---|---|
| Market cap | CHF 2.67b |
| Earnings (TTM) | CHF 80.80m |
| Revenue (TTM) | CHF 1.10b |
33.0x
P/E Ratio2.4x
P/S RatioIs DAE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DAE income statement (TTM) | |
|---|---|
| Revenue | CHF 1.10b |
| Cost of Revenue | CHF 842.60m |
| Gross Profit | CHF 257.90m |
| Other Expenses | CHF 177.10m |
| Earnings | CHF 80.80m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Jul 23, 2026
| Earnings per share (EPS) | 4.75 |
| Gross Margin | 23.43% |
| Net Profit Margin | 7.34% |
| Debt/Equity Ratio | 136.6% |
How did DAE perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield67%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/30 06:44 |
| End of Day Share Price | 2026/04/30 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dätwyler Holding AG is covered by 6 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Thielmann | Berenberg |
| Savana Lamce | Research Partners AG |
| Michael Inauen | Stifel, Equities Research |